FdaApplication
BLA 761384
Identifiers
- fda_app_no: BLA761384
Properties
| Property | Value |
|---|---|
| applicant_name | AbbVie Inc. |
| application_type | BLA |
| approval_date | 2025-05-14 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMRELIS | TELISOTUZUMAB VEDOTIN-TLLV | 20MG | For Injection |
| EMRELIS | TELISOTUZUMAB VEDOTIN-TLLV | 100MG | For Injection |
2 products